Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Ocrelizumab may cause pancreatitis in some patients.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.